Taking care of systemic sclerosis patients during COVID-19 pandemic: rethink the clinical activity

Clin Rheumatol. 2020 Jul;39(7):2063-2065. doi: 10.1007/s10067-020-05191-4. Epub 2020 May 27.

Abstract

COVID-19 outbreak has quickly spread worldwide, causing a high pressure on the health-care system. In Italy, from March 8, 2020, all the deferrable clinical activities have been suspended to increase the health care offer for COVID-19 patients. The hospital organization has been modified also in order to assure non-COVID-19 patients assistance. The Scleroderma Unit of ASST Pini-CTO Hospital, in Milan, in the region mostly hit by SARS-CoV-2 in Italy, follows more than 600 patients affected by systemic sclerosis (SSc). Patients with SSc need a close follow-up with a regular screening of organ involvement and frequent intravenous treatments. All SSc patients have been educated about ministerial directives to limit COVID-19 spread. The organization of our Scleroderma Unit has been quickly rethought to assure SSc patients assistance in safety for them and for health-care workers during urgent visits or infusion therapies. Using electronic way of communication with frequent virtual contact and guarantying home deliveries of some therapies, we allowed a continuity of care also outside the Hospital.

Keywords: COVID-19; Patient care; Public health; Systemic sclerosis.

MeSH terms

  • Betacoronavirus / isolation & purification
  • COVID-19
  • Comorbidity
  • Coronavirus Infections* / epidemiology
  • Coronavirus Infections* / prevention & control
  • Critical Pathways* / organization & administration
  • Critical Pathways* / trends
  • Disease Management
  • Hospital Units / organization & administration*
  • Humans
  • Infection Control / organization & administration*
  • Italy / epidemiology
  • Organizational Innovation
  • Pandemics* / prevention & control
  • Pneumonia, Viral* / epidemiology
  • Pneumonia, Viral* / prevention & control
  • Rheumatology / methods
  • SARS-CoV-2
  • Scleroderma, Systemic* / epidemiology
  • Scleroderma, Systemic* / therapy